Literature DB >> 18158802

Transduodenal local resection for low-risk group ampulla of vater carcinoma.

Joon Seong Park1, Dong Sup Yoon, Young Nyun Park, Woo Jung Lee, Hoon Sang Chi, Byong Ro Kim.   

Abstract

BACKGROUND: Carcinoma of the ampulla of Vater has a more favorable prognosis, compared to other malignant tumors of the periampullary region, because it usually presents with symptoms in the early stage. However, treatment by local resection only of the ampullary carcinoma remains controversial. The aim of this study was to evaluate the treatment results of the ampulla of Vater carcinoma according to different types of operation in low-risk-group patients.
METHODS: We retrospectively reviewed the medical records of 17 low-risk-group patients among a total of 102 patients with ampulla of Vater carcinoma who had underwent curative surgery from 1992 to 2002. All specimens were critically reviewed by a single expert pathologist, and the relationship between surgical outcomes and operation type was assessed.
RESULTS: The low-risk group was comprised of 10 men and 7 women with a median age of 57.8 years. Thirteen of 17 patients underwent a pancreaticoduodenectomy (PD) or a pylorus preserving pancreaticoduodenectomy (PPPD), while 4 patients underwent a transduodenal local resection (TDLR). The operation time was significantly shorter in the TDLR group, compared to the PD or PPPD groups. Among the 17 patients, there was only 1 case of recurrence in the inguinal area 33 months after the pancreaticoduodenectomy.
CONCLUSIONS: Transduodenal local resection is a comparable mode of operation for low-risk-group patients with Ampulla of Vater carcinoma. In particular, it is essential to evaluate the invasion depth in preoperative endoscopic ultrasonography, cell differentiation in preoperative biopsy, and positivity of resection margin accurately by using frozen section during the operation.

Entities:  

Mesh:

Year:  2007        PMID: 18158802     DOI: 10.1089/lap.2006.0134

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  9 in total

1.  Is local resection adequate for T1 stage ampullary cancer?

Authors:  Albert Amini; John T Miura; Thejus T Jayakrishnan; Fabian M Johnston; Susan Tsai; Kathleen K Christians; T Clark Gamblin; Kiran K Turaga
Journal:  HPB (Oxford)       Date:  2014-11-14       Impact factor: 3.647

2.  Laparoscopic transduodenal local resection of periampullary neuroendocrine tumor: a case report.

Authors:  Ren-Chao Zhang; Xiao-Wu Xu; Di Wu; Yu-Cheng Zhou; Harsha Ajoodhea; Ke Chen; Yi-Ping Mou
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

3.  Combined excision and ablation of ampullary tumors with biliary or pancreatic intraductal extension is effective even in malignant neoplasms.

Authors:  Enrique Pérez-Cuadrado-Robles; Hubert Piessevaux; Tom G Moreels; Ralph Yeung; Tarik Aouattah; Mina Komuta; Hélène Dano; Anne Jouret-Mourin; Pierre H Deprez
Journal:  United European Gastroenterol J       Date:  2019-01-12       Impact factor: 4.623

Review 4.  Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Authors:  James Askew; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

5.  Extraduodenal papillectomy: a feasible alternative method of total papillectomy.

Authors:  Naohiro Sata; Masaru Koizumi; Yuji Kaneda; Yasunao Ishiguro; Akira Kurogochi; Kazuhiro Endo; Hideki Sasanuma; Yasunaru Sakuma; Alan Lefor; Yoshikazu Yasuda
Journal:  J Gastrointest Surg       Date:  2013-12-18       Impact factor: 3.452

6.  Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection.

Authors:  Jf Feng; Xm Zhou; Wm Mao
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

7.  Proposed indications for limited resection of early ampulla of Vater carcinoma: clinico-histopathological criteria to confirm cure.

Authors:  Koichi Aiura; Taizo Hibi; Hiroto Fujisaki; Minoru Kitago; Minoru Tanabe; Shigeyuki Kawachi; Osamu Itano; Masahiro Shinoda; Hiroshi Yagi; Yohei Masugi; Michiie Sakamoto; Yuko Kitagawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-11       Impact factor: 7.027

8.  Therapeutic options for ampullary carcinomas. A review.

Authors:  Dileep Kumar Reddy Regalla; Rojymon Jacob; Ashish Manne; Ravi Kumar Paluri
Journal:  Oncol Rev       Date:  2019-09-10

9.  Comparison of Oncologic Outcomes between Transduodenal Ampullectomy and Pancreatoduodenectomy in Ampulla of Vater Cancer: Korean Multicenter Study.

Authors:  Seung-Soo Hong; Sung-Sik Han; Wooil Kwon; Jin-Young Jang; Hee-Joon Kim; Chol-Kyoon Cho; Keun-Soo Ahn; Jae-Do Yang; Youngmok Park; Seog-Ki Min; Ju-Ik Moon; Young-Hoon Roh; Seung-Eun Lee; Joon-Seong Park; Sang-Geol Kim; Chi-Young Jeong; Jin-Seok Heo; Ho-Kyoung Hwang
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.